Cancer Research Institute
Technology Impact Award
23:59 Eastern Time; LOI deadline, invited full proposal due 1 March 2027
Last updated:
The Technology Impact Award provides up to $600,000 over 2-4 years for early-stage technological innovations in cancer immunotherapy, including computational tools, profiling systems, visualization platforms, culture methods, and novel therapeutic approaches. Applicants must hold tenure-track positions at not-for-profit research institutions; co-PIs are encouraged. The call does not fund clinical trials or development of existing technologies, focusing instead on pre-development stage concepts with innovation potential.
Details
| Funder | Cancer Research Institute |
| Budget | Up to $600,000 + up to 10% indirect costs |
| Deadline | 15 November 2026 |
| Duration | 2-4 years |
| Consortium | Optional — clinical cancer immunologists and technology developers are encouraged to collaborate; co-PIs eligible |
| Application | 2-stage: Letter of Intent → invited full proposal |
| Frequency | Annual |
Eligibility & scope
Seed funding for early-stage, pre-development technology concepts in cancer immunotherapy; applicants must hold a tenure-track position at a not-for-profit research center or institution. Does not fund clinical trials or refinement of existing technologies.
Who Should Apply
- •Tenure-track researchers at not-for-profit academic or research institutions
- •Early-stage technology developers in cancer immunotherapy (computational, profiling, visualization, or culture systems)
- •Researchers with genuinely novel or pre-development stage concepts, not incremental advances on existing tools
- •Investigators open to multi-PI collaboration; co-PI engagement strengthens applications
Key Dates
- •Letter of Intent deadline: 16 November 2026, 23:59 Eastern Time
- •Invited full proposal deadline: 12 March 2027
- •2-4 year project duration
- •Annual call cycle
Tips for Applicants
- ✓The two-stage format is gating: use the LOI (concise) to demonstrate novelty clearly; full proposals are lengthy and only invited groups advance, so nail the concept first.
- ✓Emphasize why your technology is pre-development or early-stage, not an extension of an existing tool, CRI screens hard for genuine innovation.
- ✓Co-PI letters from collaborators (especially experimental immunologists if your team is computational-heavy, or vice versa) can swing the innovation score.
Frequently Asked Questions
What types of technology innovations does the Cancer Research Institute Technology Impact Award fund?
Early-stage, pre-development innovations in cancer immunotherapy, including computational tools, profiling systems, visualization platforms, culture methods, and novel therapeutics. Clinical trials and continuation of existing technologies are not supported.
Who is eligible to apply for the Technology Impact Award?
Researchers holding a tenure-track position at a not-for-profit research institution. Co-PIs are encouraged.
What is the budget range for the Technology Impact Award?
Up to $600,000 over 2-4 years, plus up to 10% indirect costs.
What is the timeline for the Technology Impact Award application?
Letter of Intent due 16 November 2026 at 23:59 Eastern Time; invited full proposals due 12 March 2027.
Summary generated by AI based on published grant information. Always verify details on the funder's website.
Similar grants
CRI Technology Impact Award
Cancer Research InstituteDeadline: 16 Nov 2026$600,000CRI Clinical Innovator
Cancer Research InstituteDeadline: 1 Dec 2026$1MCri Ignite Award
Cancer Research InstituteDeadline: 11 Jan 2027$1.05MIgnite Award
Cancer Research InstituteDeadline: 11 Jan 2027$1.05MCRI Lloyd J. Old STAR Program
Cancer Research InstituteDeadline: 15 Jan 2027$1.25M
Browse Related
Could Technology Impact Award be right for you?
See your personalised match score for this grant and others in 30 seconds. No signup needed to preview.
See my matches free →